Meta-analysis
Open access
Aug 2026
The clinical value of adding immune checkpoint inhibitors to radiotherapy for cancer: a systematic review and meta-analysis
Adding immunotherapy to radiotherapy can provide significant clinical benefits for patients with NSCLC and cervical cancer, and the addition of these ICIs in the adjuvant stage is supported.
Kun Liu, Youwen Zhu, Hong Zhu
· Annals medicus · 0 citations